About the GHR journal
Senior Journal Editor - Dr Emma Pitchforth
Global Health Research (GHR) was launched in 2024 and is indexed by CINAHL Ultimate and NCBI Bookshelf.
Remit
Research funding through the NIHR GHR portfolio that is for the direct and primary benefit of people in low- and middle-income countries (LMICs).
The programme’s current strategic priority areas for research are:
- addressing the shifting global burden of disease
- developing health systems to identify and respond to population needs,
- building resilience to tackle future global health threats, and
- strengthening research capacity in LMICs through equitable partnerships between LMIC and UK researchers.
These priorities are driven by NIHR principles of promoting community engagement and involvement, equitable partnerships and funding high-quality, policy-relevant, impactful research.
Publication criteria
Manuscripts are published in GHR if
- they have resulted from work funded by the Global Health Research portfolio, and
- they are of a sufficiently high scientific quality as assessed by the external reviewers and journal editors.
The journal will only publish findings from NIHR-funded research, therefore speculative submissions are not considered and there are no article processing charges (APCs) or article submission charges for authors.
Publication frequency
The journal will follow a continuous publication schedule, with manuscripts published as and when they are ready for publication.
Publication process
Articles are delivered to the editorial office at the NIHR Coordinating Centre. We manage the editorial review process between the editors, reviewers and authors, ahead of sending the manuscript to the production house. We also co-ordinate the editorial boards, and manage the relationship with the production house.
In preparing and submitting their articles, researchers are expected to follow the Information for authors guidance.
Publication ethics
We take an active role in the prevention of plagiarism, falsification of data, fabrication of results and other areas of ethical misconduct. GHR is a member of the Committee on Publication Ethics (COPE). This is a UK-based charity, with over 7000 members worldwide from all academic fields. COPE advises editors and publishers on how to handle cases of research and publication misconduct.
Plagiarism detection software is used to check all articles submitted to Global Health Research.
Should there be concerns that a project suffered misconduct in research, publication, or professional behaviour, the case may be discussed in confidence with the editorial board, or referred to COPE or any other relevant authorities.
We support the use of a declaration of transparency. For further information please see the Equator website: /www.equator-network.org
Please see our policies for more information about our requirements for authors.
Our community of reviewers plays a vital part in maintaining and improving the quality of the journal. Reviewers are usually sourced from our database of experts, from author suggestions, or from peer-to-peer recommendations. Typically, for each article, four reviewers are chosen for suitability by the editors, and will cover a variety of relevant areas in their reviews. GHR has a system of single blind review, where authors do not know who has reviewed or edited their articles. Please see our be a Reviewer page for more information.
Our production house is Newgen Publishing UK. We have a dedicated project management team at Newgen who are responsible for managing the production stage following editorial review. This involves copy-editing, typesetting and producing the electronic files of manuscripts. When manuscripts reach Newgen, they are copy-edited and proofread by professional writers and proof-readers who liaise directly with the manuscript authors and editors.
All articles published in GHR are open access. For further information please see the Journals Library open access statement.
The NIHR Journals Library is committed to maintaining the content it publishes and to alerting readers to changes if and when they occur.
Research
The Global Health Research Portfolio was established in 2016 by the Department of Health and Social Care (DHSC), following publication of the 2015 UK Aid Strategy.
The Global Health Research Portfolio addresses the diverse health needs of people in low- and middle-income countries (LMICs). This is funded by the UK Government's commitment to Official Development Assistance (ODA; also known as UK Aid) to fund applied health research and strengthen research capacity. This is directly and primarily relevant to addressing the unmet needs of LMIC communities, health system priorities and the evolving global burden of disease.
The Global Health Research Portfolio supports the objectives of the UK Aid Strategy and the United Nations’ (UN) Sustainable Development Goals to improve the health and welfare of the most vulnerable populations living in low resource contexts. This complements the research funding of other UK Government ODA research funders, such as the Foreign, Commonwealth & Development Office (FCDO) and the Department for Business, Energy & Industrial Strategy (BEIS).
For further information on the Global Health Research Portfolio and its remit please visit the Global Health Research Portfolio webpage.